Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testotoxicosis: current viewpoint.

Edward O Reiter1, Ensio Norjavaara

  • 1Department of Pediatrics, Baystate Children's Hospital, Tufts University School of Medicine, Springfield, MA 01199, USA. edward.reiter@bhs.org

Pediatric Endocrinology Reviews : PER
|December 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Puberty promoting low dose testosterone treatment improved wellbeing and emotional state in boys with self-limited delayed puberty.

Journal of pediatric endocrinology & metabolism : JPEM·2026
Same author

Pharmacological treatment for pubertal progression in boys with delayed or slow progression of puberty: A small-scale randomized study with testosterone enanthate and testosterone undecanoate treatment.

Frontiers in endocrinology·2023
Same author

Growth and Growth Hormone through the Ages: Art and Science.

Hormone research in paediatrics·2022
Same author

Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.

The lancet. Diabetes & endocrinology·2022
Same author

Editorial: History of Growth Hormone: Animal to Human.

Frontiers in endocrinology·2021
Same author

Human Growth and Growth Hormone: From Antiquity to the Recominant Age to the Future.

Frontiers in endocrinology·2021

Testotoxicosis, a form of precocious puberty in boys, is caused by a luteinizing hormone (LH) receptor mutation. New therapies combining anti-androgens and aromatase inhibitors show promise for managing this condition.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Endocrinology
  • Molecular Endocrinology

Background:

  • Testotoxicosis is gonadotropin-independent precocious puberty in boys, characterized by early puberty onset, accelerated growth, and reduced adult height.
  • It results from activating mutations in the luteinizing hormone (LH) receptor, causing elevated sex steroids despite low LH levels.
  • Traditional therapies targeting steroidogenesis have shown side effects, necessitating exploration of alternative treatments.

Purpose of the Study:

  • To evaluate the efficacy and tolerability of novel therapeutic combinations for testotoxicosis.
  • To investigate the impact of combined anti-androgen and aromatase inhibitor therapy on growth and predicted adult height in patients with testotoxicosis.

Main Methods:

  • Review of existing literature on testotoxicosis treatment.

Related Experiment Videos

  • Analysis of a phase II study exploring the combination of bicalutamide (anti-androgen) and anastrozole (aromatase inhibitor).
  • Assessment of treatment effects on height velocity, predicted adult height, and hormonal profiles.

    • Main Results:

    • Previous combination therapy with spironolactone and testolactone decreased height velocity and improved predicted adult height.
    • The combination of bicalutamide and anastrozole is being studied in a phase II trial.
    • These agents are generally well-tolerated and effectively inhibit testosterone activity and estrogen production.

    Conclusions:

    • Novel therapeutic strategies for testotoxicosis are focusing on inhibiting androgen activity and estrogen production.
    • Combinations of anti-androgens and aromatase inhibitors represent a promising approach to manage testotoxicosis, potentially improving outcomes and reducing side effects.
    • Further research, including ongoing phase II studies, is crucial to confirm the long-term efficacy and safety of these new treatment regimens.